Clinical trial
Effect of Ischemic Preconditioning on Relapse of Nonvalvular Atrial Fibrillation After Electrocardioversion
NCT05342220 is registered in ClinicalTrials.gov with St. Josefs-Hospital Wiesbaden GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Ischemic Preconditioning on Relapse of Nonvalvular Atrial Fibrillation After Electrocardioversion
- Lead sponsor
- St. Josefs-Hospital Wiesbaden GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- June 30, 2024
- Enrollment
- 240 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.